The marine ecosystem is more and more acknowledged as a source of potential
anticancer agents. After the identification of a potential substance sever
al hurdles have to be overcome before a marine candidate can enter the clin
ic, Amongst these are the establishment of a method which ensures sufficien
t supply and, which is the focus of this review, the development of a clini
cally useful pharmaceutical formulation, General issues with respect to the
pharmaceutical development of marine anticancer agents will be discussed,
which will be illustrated by highlighting aspects of the pharmaceutical dev
elopment and clinical use of some representative compounds. [(C) 2000 Lippi
ncott Williams & Wilkins.].